Fact CheckerSign in

NCT05706558Recruiting

Retrospective Review of Esophageal Cancer at MSKCC

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.

Status (registry)
Recruiting
Study type
Observational
Enrollment
4000 (estimated)
First submitted
23 Jan 2023
Start date
13 Dec 2016
Primary completion date
28 Feb 2027
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT05706558

What you commit to

  • Study type: Observational
  • Planned participants: 4000
  • From 13 Dec 2016 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Evidence of distant metastatic disease

Other

  • Pathologic staged T0-2 (pT0-2) or T4 tumors (pT4)
  • Patients with histologic types other than EAC or ESCC, dysplasia or carcinoma in situ without tumor invasion,
  • Patients undergoing salvage esophagectomy
  • Patients with a positive proximal or distal margin

Who the study is looking for

  • Histologically confirmed esophageal adenocarcinoma (EAC) or esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy
  • Pathologic staged T3 tumors (pT3)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.